SIVB News Alert Svb Financial Group (SIVB) 126.13 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Svb Financial Group (SIVB) 126.13 $SIVB

BofA Unit Aided Hedge Fund & Other Clients Avoid Taxes - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 10:50AM CST
As per the Wall Street Journal, BofA, through its U.S. banking subsidiary, had financed contentious trades that helped hedge funds and other clients avoid taxes.
NTRS: 70.08 (-0.51), JPM: 59.67 (+0.10), SIVB: 126.13 (+1.03), BAC: 16.61 (-0.06)

Will SVB Financial (SIVB) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 7:09AM CST
Will SVB Financial (SIVB) Continue to Surge Higher?
SIVB: 126.13 (+1.03)

JPMorgan Settles Bear Stearns Mortgage Lawsuit for $500M - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 04, 6:31PM CST
JPMorgan will pay $500 million to resolve a class-action lawsuit filed over nearly $17.58 billion worth of MBS sold by Bear Stearns Cos.
JPM: 59.67 (+0.10), WAL: 28.65 (+0.23), C: 51.20 (+0.31), SIVB: 126.13 (+1.03)

SVB Financial Group's Underwhelming Quarter And Asset Divestiture Are Reasons To Sell
Dallas Salazar - at Seeking Alpha - Sat Jan 31, 1:58PM CST

SIVB: 126.13 (+1.03)

Silicon Valley Bank Bestows Clinicient $7 Million in Debt Facilities
PR Newswire - Tue Jan 27, 10:00AM CST
Clinicient Inc., a leader in outpatient rehabilitation business solutions, today announced that it secured $7 million in total debt facilities from Silicon Valley Bank. As Clinicient proudly funds its own working capital with earned revenue, the Silicon Valley Bank's funding will be used exclusively for capital expenditures that enhance its integrated software and revenue cycle management services.
SIVB: 126.13 (+1.03)

SVB Financial Group Prices $350 Million, 3.5% Senior Notes Offering
PR Newswire - Mon Jan 26, 7:00PM CST
SVB Financial Group (Nasdaq: SIVB) today priced an underwritten offering of $350 million in aggregate principal amount of its 3.5% senior notes due 2025 (the "Notes" . The Notes will be sold at 99.916% of the principal amount and will bear interest semiannually. The offering is expected to close on January 29, 2015.
SIVB: 126.13 (+1.03)

3 Financial Stocks Pushing Sector Growth
at The Street - Fri Jan 23, 11:03AM CST
TheStreet highlights 3 stocks pushing the financial sector higher today.
COF: 78.88 (-0.41), SIVB: 126.13 (+1.03), ETFC: 25.65 (-0.26)

SVB Financial (SIVB) Beats Q4 Earnings on Top-Line Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 23, 9:10AM CST
SVB Financial (SIVB) reported fourth-quarter 2014 adjusted earnings per share of $1.37, beating the Zacks Consensus Estimate of $1.29. Further, the bottom line compared favorably with the year-ago figure of $1.27 per share.
BOH: 60.34 (+0.51), SIVB: 126.13 (+1.03), NRIM: 22.20 (+0.05), ZION: 26.32 (+0.05)

SVB Financial Group's (SIVB) CEO Greg Becker on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Jan 22, 11:44PM CST

SIVB: 126.13 (+1.03)

SVB Financial Group (SIVB) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Jan 22, 4:55PM CST

SIVB: 126.13 (+1.03)

SVB tops Street 4Q forecasts
Automated Insights - Thu Jan 22, 3:43PM CST
SANTA CLARA, Calif. (AP) _ SVB Financial Group (SIVB) on Thursday reported fourth-quarter earnings of $58.8 million.
SIVB: 126.13 (+1.03)

SVB Financial beats by $0.08, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Jan 22, 3:27PM CST

SIVB: 126.13 (+1.03)

SVB Financial Group Announces Availability Of Quarterly And Full-Year Financial Results
PR Newswire - Thu Jan 22, 3:22PM CST
SVB Financial Group (NASDAQ: SIVB) has released its financial results for the quarter and year ended December 31, 2014. Please visit SVB's Investor Relations website at SVB.com to view the earnings release.
SIVB: 126.13 (+1.03)

Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Jan 21, 4:35PM CST

MXIM: 34.92 (+0.36), SWKS: 81.85 (-0.57), WAL: 28.65 (+0.23), ALTR: 35.66 (+0.45), HBHC: 29.74 (-0.29), MSCC: 30.87 (+0.06), PLCM: 13.94 (+0.03), CYN: 90.32 (+0.49), HXL: 45.51 (+0.48), SBUX: 91.58 (-0.24), ISRG: 510.73 (+3.02), CE: 57.98 (+0.22), COF: 78.88 (-0.41), DGII: 10.31 (+0.16), FII: 35.09 (+0.20), RMD: 66.25 (+0.79), SIVB: 126.13 (+1.03), ETFC: 25.65 (-0.26), KLAC: 63.64 (-0.23), EGHT: 7.96 (+0.03), INFN: 17.56 (-0.10)

Silicon Valley Bank Foresees Breakout Year Ahead for US Fine Wine Business
PR Newswire - Wed Jan 21, 10:00AM CST
Silicon Valley Bank, a leading provider of commercial banking services to the innovation sector and the wine industry, releases its Annual State of the Wine Industry Report in a live broadcast from the SVB TV studio today.
SIVB: 126.13 (+1.03)

Work Market Closes $20 Million in Growth Capital
Marketwired - Wed Jan 21, 6:00AM CST
Work Market, the SaaS solution that helps companies find, engage, manage and pay their freelance and independent contractor workforce from a single platform, today announced that it has raised $20 million in growth capital. The investment was led by Union Square Ventures, with participation by Spark Capital, SoftBank Capital, Industry Ventures and Silicon Valley Bank.
SIVB: 126.13 (+1.03), TWTR: 48.50 (+0.55)

Minerva Neurosciences Announces $15 Million Debt Facility With Oxford Finance LLC and Silicon Valley Bank
GlobeNewswire - Tue Jan 20, 3:01PM CST
Minerva Neurosciences, Inc. (Nasdaq:NERV) today announced it has entered into a $15 million debt facility with Oxford Finance LLC (Oxford) and Silicon Valley Bank (SVB). The financing positions Minerva to broaden and advance the clinical development program for MIN-101, the company's investigational compound in development for the treatment of schizophrenia. The next phase in development of MIN-101 will include chemical manufacturing control (CMC) scale-up activities and preparatory work for late stage clinical development.
NERV: 4.68 (+0.09), SIVB: 126.13 (+1.03)

First Republic (FRC) Q4 Core Earnings Meet, Revs Up Y/Y (revised) - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 20, 11:49AM CST
First Republic Bank (FRC) reported fourth-quarter 2014 core earnings per share of 72 cents, matching the Zacks Consensus Estimate.
BOH: 60.34 (+0.51), SIVB: 126.13 (+1.03), FRC: 56.41 (-0.38), ZION: 26.32 (+0.05)

Westamerica Reports In-Line Q4 Earnings, Shares Down 1.7% - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 16, 8:20AM CST
Lower operating expenses drove Westamerica Bancorp's fourth-quarter 2014 earnings of 58 cents per share. The figure came in line with the Zacks Consensus Estimate. However, it was lower than 60 cents earned in the year-ago quarter.
WABC: 43.59 (+0.47), WAL: 28.65 (+0.23), SIVB: 126.13 (+1.03), CYN: 90.32 (+0.49)

First Republic (FRC) Q4 Core Earnings Miss, Revenues Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 16, 8:00AM CST
First Republic Bank (FRC) reported fourth-quarter 2014 core earnings per share of 67 cents, missing the Zacks Consensus Estimate of 72 cents
BOH: 60.34 (+0.51), SIVB: 126.13 (+1.03), FRC: 56.41 (-0.38), ZION: 26.32 (+0.05)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exciting Developments in Lumwana's Super Pit Expansion

Updated Category News Views 162

Back when Barrick Gold Corporation dropped the news about the Lumwana Super Pit Expansion, traders had their ears perked up. This $2 billion project was set to redefine copper mining in Zambia, and let me tell ya, folks were buzzing like bees at a honey convention. Lumwana Expansion: The Big Picture The official launch ceremony back then saw Zambian President Hakainde...

Continue Reading
Understanding the P/E Ratio for Arbor Realty Trust's Future

Updated Category News Views 97

Understanding Arbor Realty Trust Inc. and Its P/E Ratio Presently, Arbor Realty Trust Inc. (NYSE: ABR) is trading at a price of $7.78, reflecting a decrease of 0.38% for the day. This decline has culminated in a more significant decrease of 12.78% over the past month, and a notable drop of 44.17% over the past year. Such trends pique the interest of long-term shareholders...

Continue Reading
Investors Should Reach Out to Kuehn Law Regarding DRVN Issues

Updated Category News Views 177

Contact Kuehn Law for Driven Brands Holdings Inc. Investors Kuehn Law, PLLC, a law firm specializing in shareholder litigation, is looking into potential fiduciary breaches by officers and directors of Driven Brands Holdings Inc. (NASDAQ: DRVN). The investigation focuses on allegations that insiders misrepresented the company’s integration capabilities of acquired...

Continue Reading
Understanding Revvity's Short Interest and Market Sentiment

Updated Category News Views 118

Revvity short interest: what’s changed Revvity (RVTY) has seen a fresh uptick in short positioning. Since the last report, its short percent of float has climbed by 10.95%. In total, an estimated 4.15 million shares are sold short, which equals 4.46% of the company’s available float. Based on recent trading activity, it would take about 3.81 days, on average, for...

Continue Reading
Upcoming Q3 Results Preview for National Healthcare Properties

Updated Category News Views 189

National Healthcare Properties and Their Upcoming Financial Disclosure National Healthcare Properties, Inc. is set to unveil its financial results for the third quarter, specifically for the period that concluded on September 30. This highly anticipated announcement is scheduled for a Wednesday, following the market close. Webcast Details for the Financial Results To...

Continue Reading